Four Component Meningococcal Capsular Group B Vaccine in Preterm Infants

被引：3
|
作者：
Sadarangani, Manish [1 ,2 ,3 ,4 ]
Barlow, Sheula [2 ,3 ,4 ]
Anthony, Mark [4 ]
Pollard, Andrew J. [2 ,3 ,4 ]
机构：
[1] Univ British Columbia, BC Childrens Hosp, Res Inst, Vaccine Evaluat Ctr, Vancouver, BC, Canada
[2] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England
[3] NIHR Oxford Biomed Res Ctr, Oxford, England
[4] Oxford Univ Hosp NHS Fdn Trust, Dept Paediat, Oxford, England
来源：
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2017年 / 6卷 / 03期
关键词：
ROUTINE INFANT; IMMUNOGENICITY; VACCINATIONS; IMMUNIZATION; RECOMBINANT;
D O I：
10.1093/jpids/pix013
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：309 / 310
页数：2
相关论文
共 50 条
  • [21] Immunogenicity of hepatitis B vaccine in preterm infants
    Blondheim, O
    Bader, D
    Abend, M
    Peniakov, M
    Reich, D
    Potesman, I
    Handsher, R
    Gidoni, I
    Linder, N
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1998, 79 (03): : F206 - F208
  • [22] Immunogenicity of hepatitis B vaccine in preterm infants
    Kim, SC
    Chung, EK
    Hodina, RL
    DeMaio, J
    West, DJ
    Jawad, AF
    Watson, B
    PEDIATRICS, 1997, 99 (04) : 534 - 536
  • [23] A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide-CRM197 with a meningococcal group C conjugate vaccine in healthy infants:: Challenge phase
    Riddell, Anna
    Buttery, Jim P.
    McVernon, Jodie
    Chantler, Tracey
    Lane, Laura
    Bowen-Morris, Jane
    Diggle, Linda
    Morris, Rhonwen
    Lockhart, Steven
    Pollard, Andrew J.
    Cartwright, Keith
    Moxon, E. Richard
    VACCINE, 2007, 25 (19) : 3906 - 3912
  • [24] Safety surveillance of the four-component meningococcal group B vaccine (Bexsero®): vaccine adverse event reporting system (VAERS), January 2015-June 2018
    Perez-Vilar, Silvia
    Dores, Graca M.
    Lewis, Paige W.
    Ng, Carmen S.
    Su, John R.
    Cano, Maria V.
    Duffy, Jonathan M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 450 - 451
  • [25] MENINGOCOCCAL GROUP-B VACCINE IMMUNOGENIC IN MAN
    ZOLLINGER, WD
    MANDRELL, RE
    HANSEL, H
    GRIFFISS, JM
    CLINICAL RESEARCH, 1979, 27 (02): : A361 - A361
  • [26] VACCINE AGAINST MENINGOCOCCAL GROUP-B DISEASE
    LIFELY, MR
    MORENO, C
    LANCET, 1986, 1 (8474): : 214 - 215
  • [27] Group B meningococcal vaccine: recommendations for UK use
    Pollard, Andrew J.
    Riordan, Andrew
    Ramsay, Mary
    LANCET, 2014, 383 (9923): : 1103 - 1104
  • [28] SAFETY AND IMMUNOGENICITY OF A GROUP 29E MENINGOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE IN ADULTS
    GRIFFISS, JM
    BRANDT, BL
    ALTIERI, PL
    PIER, GB
    BERMAN, SL
    INFECTION AND IMMUNITY, 1983, 39 (01) : 247 - 252
  • [29] Immunogenicity and safety of conjugate meningococcal group C vaccine in infants.
    Rennels, MB
    Edwards, KM
    Keyseding, HL
    Reisinger, KS
    Hogerman, DA
    Kimura, A
    Malinoski, FJ
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1083 - 1083
  • [30] Immunogenicity of hepatitis B vaccine in term and preterm infants
    Belloni, C
    Chirico, G
    Pistorio, A
    Orsolini, P
    Tinelli, C
    Rondini, G
    ACTA PAEDIATRICA, 1998, 87 (03) : 336 - 338
12345